News and Events
Stay up to date with news and events
Could halting CAG expansions be a new treatment for HD?
A recent paper from a group at UMass Chan Medical School, spearheaded by Dr. Daniel O’Reilly and led by Dr. Anastasia Khvorova, used genetic strategies…
Tipping the balance; new insights into HD genetic modifiers
Genetic modifiers can influence when HD symptoms begin. Some of these genes encode for different types of molecular machines whose normal job is to repair…
Drug to treat movement symptoms of HD approved by FDA
The vast majority of people with Huntington’s disease experience movement symptoms known as chorea. Valbenazine, also known as INGREZZA, has recently been approved by the…
Youthful competitors: young brain cells oust the old
When you lose something, an easy solution can be to just replace it. But what if the something you’ve lost are cells in the brain?…
Clinical Trial Update: Phase 1b/2a SELECT-HD
HD-Community-Letter-August-3-2023